UCF-101 ameliorates traumatic brain injury by promoting microglia M2 polarization via AMPK/NF-κB pathways in LPS-induced BV2 cells
- PMID: 39739143
- DOI: 10.1007/s10735-024-10336-9
UCF-101 ameliorates traumatic brain injury by promoting microglia M2 polarization via AMPK/NF-κB pathways in LPS-induced BV2 cells
Abstract
Traumatic brain injury (TBI) is a common neurosurgical emergency. As a macrophage in brain, microglia involves in secondary TBI injury. UCF-101, an Omi/HtrA2 inhibitor, protects against neurological disorders. This study aims to investigate the effects of UCF-101 in TBI and its mechanism. Mouse microglia cell BV2 cells were exposed to 1 µg/mL LPS to construct TBI in vitro models. Following CCK8 assay, cells were treated with LPS + UCF-101 (2, 5, 10 µM), LPS + Compound C (AMPK inhibitor, 20 µM), and LPS + UCF-101 + Compound C groups. With lactate dehydrogenase (LDH) content detection, ELISA and qRT-PCR assays were used to measure proinflammatory factors. Biomarkers of M1 (CD16/32 and iNOS) and M2 phenotypes (CD206), as well as AMPK/NF-κB pathway-related protein expression were assessed by flow cytometry, immunofluorescence, and Western blot methods. There was a decrease in M1 phenotype biomarkers and an increase in M2 phenotype biomarkers after UCF-101 treatment. UCF-101 exposure reduced TNF-α, LDH, IL-1β, IL-6, IL-8, p-NF-κB p65/NF-κB p65, and activated p-AMPK α (T172)/AMPK α (T172) expression. Importantly, further Compound C treatment counteracted these effects of UCF-101. In conclusion, UCF-101 ameliorates TBI by promoting microglia M2 polarization via AMPK/NF-κB pathways in LPS-induced BV2 cells, providing solid scientific foundation for clinical application of UCF-101 in TBI treatment.
Keywords: AMPK/NF-κB; M2 polarization; Microglia; Neuroinflammation; Traumatic brain injury; UCF-101.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflicts of interest.
References
-
- Bi F, Ma H, Ji C, Chang C, Liu W, Xie K (2020) Rhein Protects Against Neurological Deficits After Traumatic Brain Injury in Mice via Inhibiting Neuronal Pyroptosis. Front Pharmacol 11:564367. https://doi.org/10.3389/fphar.2020.564367 - DOI - PubMed - PMC
-
- Butturini E, Boriero D, Carcereri de Prati A, Mariotto S (2019) STAT1 drives M1 microglia activation and neuroinflammation under hypoxia. Arch Biochem Biophys 669:22–30. https://doi.org/10.1016/j.abb.2019.05.011 - DOI - PubMed
-
- Cai J, Yang Y, Han J, Gao Y, Li X, Ge X (2023) KDM4A, involved in the inflammatory and oxidative stress caused by traumatic brain injury-hemorrhagic shock, partly through the regulation of the microglia M1 polarization. BMC Neurosci 24(1):17. https://doi.org/10.1186/s12868-023-00784-6 - DOI - PubMed - PMC
-
- Cao C, Yang Y, Xie Z, Chen X, Shi X, Yin X, Gao J (2022) Derivatives of sarcodonin A isolated from Sarcodon scabrosus reversed LPS-induced M1 polarization in microglia through MAPK/NF-κB pathway. Bioorg Chem 125:105854. https://doi.org/10.1016/j.bioorg.2022.105854 - DOI - PubMed
-
- Capizzi A, Woo J, Verduzco-Gutierrez M (2020) Traumatic Brain Injury: An Overview of Epidemiology, Pathophysiology, and Medical Management. Med Clin North Am 104(2):213–238. https://doi.org/10.1016/j.mcna.2019.11.001 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
